Front-line chronic lymphocytic leukemia: The role of chemoimmunotherapy

被引：5

作者：

Kim, Myung Sun ^{[1
,3
]}

Prasad, Vinay ^{[2
]}

机构：

[1] Compass Oncol, Med Oncol Hematol, Portland, OR USA

[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA

[3] Compass Oncol, Hematol Med Oncol, 5050 NE Hoyt St,Suite 256, Portland, OR 97213 USA

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2023年 / 98卷 / 04期

关键词：

D O I：

10.1002/ajh.26864

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：560 / 561

页数：2

共 50 条

[41] Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Lampson, Benjamin L.
Kasar, Siddha N.
Matos, Tiago R.
Morgan, Elizabeth A.
Rassenti, Laura
Davids, Matthew S.
Fisher, David C.
Freedman, Arnold S.
Jacobson, Caron A.
Armand, Philippe
Abramson, Jeremy S.
Arnason, Jon E.
Kipps, Thomas J.
Fein, Joshua
Fernandes, Stacey
Hanna, John
Ritz, Jerome
Kim, Haesook T.
Brown, Jennifer R.
BLOOD, 2016, 128 (02) : 195 - 203
[42] Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
Massimo Gentile
Tait D. Shanafelt
Gianluigi Reda
Francesca Romana Mauro
Katja Zirlik
Stefania Ciolli
Luca Laurenti
Maria Ilaria Del Principe
Davide Rossi
Nicola Di Renzo
Stefano Molica
Francesco Angrilli
Marta Coscia
Annalisa Chiarenza
Annamaria Giordano
Giovanna Cutrona
Kari G. Chaffee
Sameer A. Parikh
Giuseppina Uccello
Idanna Innocenti
Giovanni Tripepi
Graziella D’Arrigo
Ernesto Vigna
Anna Grazia Recchia
Yair Herishanu
Lev Shvidel
Tamar Tadmor
Agostino Cortelezzi
Giovanni Del Poeta
Gianluca Gaidano
Francesco Di Raimondo
Antonino Neri
Manlio Ferrarini
Robin Foà
Aaron Polliack
Fortunato Morabito
Leukemia, 2018, 32 : 1869 - 1873
[43] Clinician and Patient Factors Influencing Treatment Decisions in Front-Line Chronic Lymphocytic Leukemia: A Qualitative Research Study
Wallington, Michael
Guillaume, Xavier
Mulvihill, Emily
Wayser, Graceanne R.
Kaul, Vandana
Graziani-Taugeron, Claire
Shahkarami, Mina
Ryan, Kellie J.
BLOOD, 2022, 140 : 10810 - 10811
[44] Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
Gentile, Massimo
Shanafelt, Tait D.
Reda, Gianluigi
Mauro, Francesca Romana
Zirlik, Katja
Ciolli, Stefania
Laurenti, Luca
Del Principe, Maria Ilaria
Rossi, Davide
Di Renzo, Nicola
Molica, Stefano
Angrilli, Francesco
Coscia, Marta
Chiarenza, Annalisa
Giordano, Annamaria
Cutrona, Giovanna
Chaffee, Kari G.
Parikh, Sameer A.
Uccello, Giuseppina
Innocenti, Idanna
Tripepi, Giovanni
D'Arrigo, Graziella
Vigna, Ernesto
Recchia, Anna Grazia
Herishanu, Yair
Shvidel, Lev
Tadmor, Tamar
Cortelezzi, Agostino
Del Poeta, Giovanni
Gaidano, Gianluca
Di Raimondo, Francesco
Neri, Antonino
Ferrarini, Manlio
Foa, Robin
Polliack, Aaron
Morabito, Fortunato
LEUKEMIA, 2018, 32 (08) : 1869 - 1873
[45] Front-Line Treatment Options for Chronic-Phase Chronic Myeloid Leukemia
Shah, Neil P.
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (03) : 220 - +
[46] Venetoclax plus obinutuzumab therapy for front-line treatment of chronic lymphocytic leukaemia
Seymour, John F.
LANCET ONCOLOGY, 2020, 21 (09): : 1128 - 1130
[47] Chronic Lymphocytic Leukemia Therapy: Beyond Chemoimmunotherapy
Delgado, Julio
Baumann, Tycho
Ghita, Gabriela
Montserrat, Emili
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (23) : 3356 - 3362
[48] Chemoimmunotherapy Is Not Dead Yet in Chronic Lymphocytic Leukemia
Brown, Jennifer R.
Kay, Neil E.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (26) : 2889 - +
[49] On the front line: first choice pharmacotherapeutics for chronic lymphocytic leukemia
Samples, Laura S.
Graf, Solomon A.
EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (15) : 1675 - 1684
[50] A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
Rodrigues, D. S.
Mancera, P. F. A.
Carvalho, T.
Goncalves, L. F.
APPLIED MATHEMATICS AND COMPUTATION, 2019, 349 : 118 - 133

← 1 2 3 4 5 →